Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component-deficient patients

International Archives of Allergy and Immunology

Volumn 130, Issue 4, 2003, Pages 314-321

  Platonov, Alexander E ^a   Vershinina, Irina V ^a   Käyhty, Helena ^b   Fijen, Cees A P ^c   Würzner, Reinhard ^e   Kuijper, Edward J ^c,d  

^a Central Research Institute of Epidemiology   (Russian Federation)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

^e UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Bactericidal effect; Complement deficiency; Meningococci; Neutrophils, human; Vaccination

Indexed keywords

AGAR; BACTERIUM ANTIBODY; IMMUNOGLOBULIN; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DEPENDENT LEUKOCYTE CYTOTOXICITY; ARTICLE; BACTERIAL GROWTH; CLINICAL ARTICLE; COLONY FORMING UNIT; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NEUTROPHIL; PLATING MEDIUM; PRIORITY JOURNAL; SERUM; SERUM BACTERICIDAL ACTIVITY; VACCINATION;

ADOLESCENT; ADULT; ANTIBODY FORMATION; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; NEUTROPHILS;

EID: 0037541054     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070219     Document Type: Article

References (35)

1. Figueroa JE, Densen P: Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991;4:359-395.
2. Fredlund H: Serum factors and polymorphonuclear leukocytes in human host defense against Neisseria meningitidis: Studies with special reference to a chemiluminometric technique. Scand J Infect Dis 1993(suppl S7):1-72.
3. Griffiss JM: Mechanism of host immunity; in Cartwright K (ed): Meningococcal Disease. Chichester, Wiley, 1995, pp 35-70.
4. Peltola H: Meningococcal vaccines. Current status and future possibilities. Drugs 1998;55: 347-366.
5. Granoff DM, Maslanka SE, Carlone GM, Plikaytis BD, Santos GF, Mokatrin A, Raff HV: A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses. Clin Diagn Lab Immunol 1998;5:479-485.
6. Platonov AE, Beloborodov VB, Vershinina IV: Meningococcal disease in patients with late complement components deficiency: Studies in the USSR. Medicine (Baltimore) 1993;72:374-392.
7. Platonov AE, Kuijper EJ, Vershinina IV, Shipulin GA, Westerdaal N, Fijen CAP, van de Winkel JGJ: Meningococcal disease and polymorphism of FcγRIIa receptors (CD32) in late complement component individuals. Clin Exp Immunol 1998;111:97-101.
8. Platonov AE, Shipulin GA, Vershinina IV, Dankert J, van de Winkel JCJ, Kuijper EJ: Association of human FcγRII (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin Infect Dis 1998;27:746-750.
9. Ross SC, Rosenthal PJ, Berberich HM, Densen P: Killing of Neisseria meningitidisby human neutrophils: Implication for normal and complement-deficient individuals. J Infect Dis 1987;155:1266-1275.
10. Söderström C, Braconier JH, Sjöholm AG, Thuresson B: Granulocte functions and Neisseria meningitidis:Influence of properdin-deficient serum. APMIS 1991;99:965-971.
11. Andreoni J, Käyhty H, Densen P: Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals. J Infect Dis 1993;168:227-231.
12. Schlesinger M, Greenberg R, Levy J, Käyhty H, Levy R: Killing of meningococci by neutrophils: Effect of vaccination on patients with complement deficiency. J Infect Dis 1994;170:449-453.
13. Estabrook MM, Christopher NC, Griffiss JM, Baker CJ, Mandrell RE: Sialyation and human neutrophil killing of groupNeisseria meningitidis. J Infect Dis 1992;166:1079-1088.
14. Maslanksa SE, Gheesling LL, LiButti DE, et al: Standardization and a multilaboratory comparison of Neisseria meningitidissero group A and C serum bactericidal assays. The Multilab-oratory Study Group. Clin Diagn Lab Immunol 1997;4:156-167.
15. Platonov AE, Beloborodov VB, Pavlova LI, Vershinina IV, Käyhty H: Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 1995;100:32-39.
16. Fijen CA, Kuijper EJ, Drogari-Apiranthitou M, Van Leeuwen Y, Daha MR, Dankert J: Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 1998;114:362-369.
17. Platonov AE, Vershinina IV, Dankert J, Kuijper EJ, Gustafson L, Käyhty H: Long-term follow-up of late complement component deficient patients vaccinated with meningococcal polysaccharide vaccine: Antibody persistence and efficacy of vaccination; in Zollinger WD, Frasch CE, Deal CD (eds): Pathogenic Neisseria. Baltimore, Tenth International Pathogenic Neisseria Conference, 1996, pp 235-236.
18. Platonov AE, Beloborodov VB, Gabrilovitch DI, Khabarov VV, Serebrovskaya LV: Immunological evaluation of late complement component-deficient individuals. Clin Immunol Immunopathol 1992;64:98-105.
19. Koroleva IS, Platonov AE, van der Ende A, Kuijper EJ, Dankert J: Characteristics of pathogenic Neisseria meningitidis in Moscow: Prevalence of 'non-European' strains. Clin Microbiol Infect 1998;4:123-128.
20. Phipps DC, West J, Eby R, Koster M, Madore DV, Quataert SA: An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods 1990;135:121-128.
21. Holder PK, Maslanksa SE, Pais LB, Dykes J, Plikaytis BD, Carlone GM: Assignment of Neisseria meningitidissero group A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC 1992. Clin Diagn Lab Immunol 1995;2:132-137.
22. Barclay GR: Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: A review; in Levin J, Alving CR, Munford RS, Redl H (eds): Bacterial Endotoxin: Lipopolysaccharides from Genes to Therapy. New York, Wiley-Liss, 1995, pp 263-272.
23. Arduino RC, Murray BE, Rakita RM: Roles of antibodies and complement in phagocytic killing of enterococci. Infect Immun 1994;62:987-993.
24. Vershinina IV, Platonov AE: Do complainants eat components? Do components eat complainants? Kinetic aspects of the interaction of complement system and meningococci; in Nassif X, Quentin-Millet M-J, Taha M-K (eds): Abstracts of the 11th International Pathogenic Neisseria Conference. Paris, Editions EDK 1998, p 77.
25. Noah N, Henderson B: Surveillance of Bacterial Meningitis in Europe 1999/2000. London, PHLS, 2001.
26. Fijen CAP: Meningococcal Disease and Complement Deficiencies in the Netherlands; thesis University of Amsterdam, 1995.
27. Lehmann AK, Sørnes S, Halstensen A: Phagocytosis: Measurement by flow cytometry. J Immunol Methods 2000;243:229-242.
28. McNeil G, Virji M, Moxon ER: Interaction of Neisseria meningitidis with human monocytes. Microb Pathog 1994;16:153-163.
29. Densen P, Mandell GL: Granuloyte phagocytes; in Mandell GL, Douglas RG Jr, Bennett JE (eds): Principles and Practice of Infectious Diseases. New York, Churchill Livingstone, 1990, pp 81-101.
30. Levy O: Antibiotic proteins of polymorphonuclear leukocytes. Eur J Haematol 1996;56:263-277.
31. Selsted ME, Quelette AJ: Defensins in granules of phagocytic and non-phagocytic cells. Trends Cell Biol 1995;5:114-119.
32. Brandtzaeg P: Pathogenesis of meningococcal infection; in Cartwright K (ed): Meningococcal Disease. Chichester, Wiley, 1995, pp 71-114.
33. Drogari-Apiranthitou M, Fijen CAP, van de Beek D, Hensen EF, Dankert J, Kuijper EJ: Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients. Clin Exp Immunol 2000;119:311-316.
34. Jones SL, Brown EJ: Functional cooperation between Fcγ receptors and complement receptors in phagocytes; in van de Winkel JCJ, Capel PJA (eds): Human IgG Fc Receptors. Austin, RG Landes, 1996, pp 148-163.
35. Morgan BP, Orren A: Vaccination against meningococcus in complement-deficient individuals. Clin Exp Immunol 1998;114:327-329.